Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease
Recruiting
N/A
Interventional Study
Atheroscleroses, Coronary
Atheroscleroses, Cerebral
Atherosclerotic Ischemic Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Vestre Viken Hospital Trust · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide and in Norway. Approximately 50% of the patients admitted to hospitals with an acute ASCVD event has had a previous event. The high number of patients being readmitted to hospitals with new ASCVD events is to a large degree explained by poor control of established risk factors such as high L…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria (all the following):
* Aged \>=18 years and signed informed consent and expected cooperation according to ICH/GCP and national/local regulations
* Hospitalised with an planned or unplanned ASCVD event and/or established atherosclerosis
* Access to a smartphone or tablet
Exclusio…
Contacts